Micaela Schachter/X, Shadi Yaghi/LinkedIn
Nov 9, 2026, 12:45
Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke
Shadi Yaghi, Professor and Chair of Neurology at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Stroke:Vascular and Interventional Neurology, adding:
“A new era in secondary stroke prevention is on the horizon!
Factor XIa inhibitors represent a potential paradigm shift in antithrombotic therapy for secondary stroke prevention, decreasing AIS without increased bleeding.”
Title: OCEANIC-STROKE: The Wave of the New Antithrombotic Therapy Era
Authors: Micaela Schachter, Shadi Yaghi
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:40Dimpy Modi: Pilot Trial Protocol Investigates Liberal vs. Restrictive Red Blood Cell Transfusion in Leukemia
-
Nov 9, 2026, 12:37Rachel Rosovsky: Pregnancy and Pulmonary Embolism Management Within a Multidisciplinary PERT Framework
-
Nov 9, 2026, 12:18Rob Maloney: Learning to Lead Without Being Needed
-
Nov 9, 2026, 12:08Anand Padmanabhan: Looking forward to presenting at ASH2026 on MGTS
-
Nov 9, 2026, 11:56Stephen Nicholls: The Search for Effective Lp(a) Therapies Continues
-
Nov 9, 2026, 11:48Chokri Ben Lamine: Redefining Toxicity Assessment After Immune Effector Cell Therapy